Mitogenic Estrogen Metabolites Alter the Expression of β-estradiol-regulated Proteins Including Heat Shock Proteins in Human MCF-7 Breast Cancer Cells

  • Kim, Seong Hwan (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology) ;
  • Lee, Su-Ui (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology) ;
  • Kim, Myung Hee (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology) ;
  • Kim, Bum Tae (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology) ;
  • Min, Yong Ki (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology)
  • Received : 2005.07.12
  • Accepted : 2005.08.30
  • Published : 2005.12.31


Estrogen metabolites are carcinogenic. The comparative mitogenic activities of $17{\beta}$-estradiol (E2) and four metabolites, 2-hydroxyestradiol (2-OHE2), 4-hydroxyestradiol (4-OHE2), $16{\alpha}$-hydroxyestrone ($16{\alpha}$-OHE1) and 2-methoxyestradiol (2-ME), were determined in estrogen receptor(ER)-positive MCF-7 human breast cancer cells. Each of the E2 metabolites caused proliferation of the MCF-7 cells, but only E2 and $16{\alpha}$-OHE1 induced a greater than 20-fold increases in transcripts of the progesterone receptor (PR) gene, a classical ER-mediated gene. This suggests that the mitogenic action of E2 and $16{\alpha}$-OHE1 could result from their effects on gene expression via the ER. E2 metabolites altered the expression of E2-regulated proteins including heat shock proteins (Hsps). $16{\alpha}$-OHE1 and 2-ME as well as E2 increased levels of Hsp56, Hsp60, $Hsp90{\alpha}$ and Hsp110 transcripts, and the patterns of these inductions resembled that of PR. Hsp56 and Hsp60 protein levels were increased by all the E2 metabolites. Levels of the transcripts of 3 E2-upregulated proteins (XTP3-transactivated protein A, protein disulfide isomerase-associated 4 protein and stathmin 1) and an E2-downregulated protein (aminoacylase 1) were also affected by the E2 metabolites. These results suggest that the altered expression of Hsps (especially Hsp56 and Hsp60) by E2 metabolites such as E2, $16{\alpha}$-OHE1 and 2-ME could be closely linked to their mitogenic action.


2-Hydroxyestradiol;2-Methoxyestradiol;4-Hydroxyestradiol;$16{\alpha}$-Hydroxyestrone;$17{\beta}$-Estradiol;Breast Cancer;Heat Shock Proteins


Grant : Chemical Genomics Research Project

Supported by : MOST (Ministry of Science and Technology), Korea Research Institute of Chemical Technology


  1. Beliakoff, J. and Whitesell, L. (2004) Hsp90: an emerging target for breast cancer therapy. Anticancer Drugs 15, 651-662
  2. Cook, R. M., Franklin, W. A., Moore, M. D., Johnson, B. E., and Miller, Y. E. (1998) Mutational inactivation of aminoacylase- I in a small cell lung cancer cell line. Genes Chromosomes Cancer 21, 320-325<320::AID-GCC5>3.0.CO;2-0
  3. Fishman, J. and Martucci, C. (1980) Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology. Clin. Endocrinol Metab. 51, 611-615
  4. Nardulli, A. M., Greene, G. L., O'Malley, B. W., and Katzenellenbogen, B. S. (1988) Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 122, 935-944
  5. Schumacher, G. and Neuhaus, P. (2001) The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors. J. Cancer Res. Clin. Oncol. 127, 405-410
  6. Soufla, G., Porichis, F., Sourvinos, G., Vassilaros, S., and Spandidos, D. A. (2005) Transcription deregulation of VEGF, FGF2, TGF-${\betha}$ 1, 2, 3 and cognate receptors in breast tumorigenesis. Cancer Lett. [Epud ahead of print]
  7. Ward, B. K., Mark, P. J., Ingram, D. M., Minchin, R. F., and Ratajczak, T. (1999) Expression of the estrogen receptorassociated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res. Treat. 58, 267-280
  8. Cappello, F., Bellafiore, M., Palma, A., David, S., Marciano, V., et al. (2003) 60 Kda chaperonin (HSP60) is over-expressed during colorectal carcinogenesis. Eur. J. Histochem. 47, 105-110
  9. Cappello, F., Bellafiore, M., Palma, M. A., Marciano, V., Martorana, G., et al. (2002-2003) Expression of 60-kDa heat shock protein increases during carcinogenesis in the uterine exocervix. Pathobiology 70, 83-88
  10. Liu, Z. J. and Zhu, B. T. (2004) Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J. Steroid Biochem. Mol. Biol. 88, 265-275
  11. Liehr, J. G. and Ricci, M. J. (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA 93, 3294-3296
  12. Liehr, J. G., Fang, W. F., Sirbasku, D. A., and Ari-Ulubelen, A. (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24, 353-356
  13. Oh, W. K. and Song, J. (2003) Cooperative interaction of Hsp40 and TPR1 with Hsp70 reverses Hsp70-HspBp1 complex formation. Mol. Cells 16, 84-91
  14. Gupta, M., McDougal, A., and Safe, S. (1998) Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 67, 413-419
  15. Isaacs, J. S., Xu, W., and Neckers, L. (2003) Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3, 213-217
  16. Flouriot, G., Brand, H., Denger, S., Metivier, R., Kos, M., et al. (2000) Identification of a new isoform of the human estrogen receptor-${\alpha}$ (hER-${\alpha}$) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J. 19, 4688-4700
  17. Clemons, M. and Goss, P. (2001) Estrogen and the risk of breast cancer. N. Engl. J. Med. 344, 276-285
  18. Darbre, P., Yates, J., Curtis, S., and King, R. J. (1983) Effect of estradiol on human breast cancer cells in culture. Cancer Res. 43, 349-354
  19. Fishman, J., Schneider, J., Hershcope, R. J., and Bradlow, H. L. (1984) Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. Steroid Biochem. 20, 1077-1081
  20. Lippert, C., Seeger, H., and Mueck, A. O. (2003) The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci. 72, 877-883
  21. Kumar, P., Mark, P. J., Ward, B. K., Minchin, R. F., and Ratajczak, T. (2001) Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 284, 219-225
  22. Rogan, E. G., Badawi, A. F., Devanesan, P. D., Meza, J. L., Edney, J. A., et al. (2003) Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24, 697-702
  23. Rozen, S. and Skaletsky, H. J. (2000) Primer3 on the WWW for general users and for biologist programmers; in Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz, S. and Misener, S. (eds.), pp. 365-386, Humana Press, Totowa
  24. Horwitz, K. B. and McGuire, W. L. (1978) Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 253, 2223-2228
  25. Lorenzo, J. (2003) A new hypothesis for how sex steroid hormones regulate bone mass. J. Clin. Invest. 111, 1641-1643
  26. Curmi, P. A., Nogues, C., Lachkar, S., Carelle, N., Gonthier, M. P., et al. (2000) Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br. J. Cancer 82, 142-150
  27. Newbold, R. R. and Liehr, J. G. (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res. 60, 235-237
  28. Swaneck, G. E. and Fishman, J. (1988) Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. USA 85, 7831-7835
  29. Balabanov, S., Zimmermann, U., Protzel, C., Scharf, C., Klebingat, K. J., et al. (2001) Tumor-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. Eur. J. Biochem. 268, 5977-5980
  30. Lewis, J. S., Thomas, T. J., Klinge, C. M., Gallo, M. A., and Thomas, T. (2001) Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cells. J. Mol. Endocrinol. 27, 293-307
  31. McGuire, W. L., Horwitz, K. B., Chamness, G. C., and Zava, D. T. (1976) A physiological role for estrogen and progesterone in breast cancer. J. Steroid Biochem. 7, 875-882
  32. Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K. E., et al. (1982) Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl. Acad. Sci. USA 79, 3047-3051
  33. Schutze, N., Vollmer, G., Tiemann, I., Geiger, M., and Knuppen, R. (1993) Catecholestrogens are MCF-7 cell estrogen receptor agonists. J. Steroid Biochem. Mol. Biol. 46, 781-789
  34. Wang, X. Y., Chen, X., Manjili, M. H., Repasky, E., Henderson, R., et al. (2003) Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma- associated antigen gp100. Cancer Res. 63, 2553-2560
  35. Hwang, T. S., Han, H. S., Choi, H. K., Lee, Y. J., Kim, Y. J., et al. (2003) Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J. Gastroenterol. Hepatol. 18, 690-700
  36. Lippert, T. H., Seeger, H., and Mueck, A. O. (2000) The impact of endogenous estradiol metabolites on carcinogenesis. Steroids 65, 357-369
  37. Seegers, J. C., Aveling, M. L., Van Aswegen, C. H., Cross, M., Koch, F., et al. (1989) The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J. Steroid Biochem. 32, 797-809
  38. Ernst, M., Schmid, C., and Froesch, E. R. (1989) Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo. Steroid Biochem. 33, 907-914
  39. Kim, S. H., Lee, S., Kim, M. H., Kim, B. T., and Min, Y. K. (2005) Protein profiling and transcript expression levels of heat shock proteins in 17${\beta}$ -estradiol-treated human MCF-7 breast cancer cells. (submitted)
  40. Li, J. J. and Li, S. A. (1987) Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc. 46, 1858-1863
  41. Csermely, P., Schnaider, T., Soti, C., Prohaszka, Z., and Nardai, G. (1998) The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol. Ther. 79, 129-168
  42. Frydman, J. and Hart, F. U. (1996) Principles of chaperoneassisted protein folding: differences between in vitro and in vivo mechanisms. Science 272, 1497-1502
  43. Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the $2^{-{\Delta}{\Delta}{\Delta}C}T$ method. Methods 25, 402-408
  44. Peattie, D. A., Harding, M. W., Fleming, M. A., DeCenzo, M. T., Lippke, J. A., et al. (1992) Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc. Natl. Acad. Sci. USA 89, 10974-10978